2018-10-11T07:17:50-05:00 2017-12-31 521754364 E COHEN AND COMPANY CPAS ONE RESEARCH COURT SUITE 101 ROCKVILLE MD 20850 990 2017-01-01 522275294 SARCOMA FOUNDATION OF AMERICA INC SARC 3012538687 9899 MAIN STREET NO 204 DAMASCUS MD 20872 RICHARD RUMSEY CEO 3012538687 2018-10-05 1 KIMBERLY HODOR MAXWELL CPA P00097044 3019176200 2018-10-05 108.31.48.50 2018-10-05 12:42:09 ED P 1BC89EA3A5582ACC6DE7C36B85888DDA7EC58A1B F429902F148CF91F85649477DA5C554694E5E68E 2017 2018-06-14 16:35:46Z MARK THORNTON MD PHD 9899 MAIN STREET NO 204 DAMASCUS MD 20872 2680506 0 X WWW.CURESARCOMA.ORG X 2001 MD WE ADVOCATE FOR SARCOMA PATIENTS BY FUNDING RESEARCH & INCREASED AWARENESS. 11 11 10 400 0 0 2027706 2093169 0 0 67230 96213 3008 94624 2097944 2284006 749312 937614 0 0 533915 550427 49320 46800 137271 429304 368894 1761851 1903735 336093 380271 5682261 6368547 466611 527038 5215650 5841509 X THE MISSION OF THE SARCOMA FOUNDATION OF AMERICA IS TO ADVOCATE FOR SARCOMA PATIENTS BY FUNDING RESEARCH AND BY INCREASING AWARENESS ABOUT THE DISEASE. THE ORGANIZATION RAISES MONEY TO PRIVATELY FUND GRANTS FOR SARCOMA RESEARCHERS AND CONDUCTS EDUCATION AND ADVOCACY EFFORTS ON BEHALF OF SARCOMA PATIENTS. 0 0 1527621 937614 165101 THE SARCOMA FOUNDATION OF AMERICA (SFA) COORDINATES A NATIONAL RESEARCH GRANT PROGRAM TO PROVIDE FUNDS TO INVESTIGATORS INTERESTED IN TRANSLATIONAL SCIENCE SARCOMA RESEARCH. IN ACCORDANCE WITH THE MISSION OF THE SFA, RESEARCH INVOLVING THE DEVELOPMENT OF NOVEL AGENTS AGAINST SARCOMA, OR RESEARCH THAT COULD POTENTIALLY LEAD TO THE DEVELOPMENT OF NOVEL AGENTS AGAINST SARCOMA, IS SUPPORTED THROUGH THIS FUNDING. THE SFA COORDINATES A PATIENT EDUCATION CONFERENCE SERIES TO BRING TOGETHER PATIENTS, SURVIVORS, CAREGIVERS, AND EXPERTS IN SARCOMA TO DISCUSS LEADING TREATMENT OPTIONS AND BREAKTHROUGHS IN SARCOMA RESEARCH. SFA ALSO CONDUCTS ADVOCACY ACTIVITIES ON BEHALF OF THE SARCOMA COMMUNITY TO ENSURE ADEQUATE FEDERAL CANCER RESEARCH FUNDING LEVELS AND POLICIES THAT POSITIVELY IMPACT SARCOMA PATIENTS. 1527621 1 1 0 1 0 0 0 0 0 1 1 0 0 0 0 1 1 0 0 0 0 0 0 1 1 0 0 1 0 0 0 0 0 0 0 0 0 1 1 1 0 0 0 0 0 0 0 1 19 0 1 10 1 0 0 0 0 1 1 1 1 0 0 0 0 X 11 11 1 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 0 0 CA CT FL GA IL KY MA MD MI MN NC NJ NY OR PA SC VA TN UT WV WI MS RI AL AR HI KS NH NM X X THE ORGANIZATION 3012538687 9899 MAIN STREET NO 204 DAMASCUS MD 20872 MARK THORNTON MD PHD PRESIDENT 4.00 X X 0 0 0 JOHN SJ BROOKS MD VICE PRESIDENT 1.00 X X 0 0 0 PATRICIA THORNTON ASSISTANT TREASURER 4.00 X X 0 0 0 STACEY BREIDINGER SECRETARY 1.00 X X 0 0 0 CHRIS CONNERY DIRECTOR 1.00 X 0 0 0 MICHAEL LEWIS DIRECTOR 1.00 X 0 0 0 PATRICK MORTIMER DIRECTOR 1.00 X 0 0 0 BRAD PRUITT DIRECTOR 1.00 X 0 0 0 BOB GOLDBERG DIRECTOR 1.00 X 0 0 0 MINA BRENNEMAN DIRECTOR 1.00 X 0 0 0 AMIRA YUNIS DIRECTOR 1.00 X 0 0 0 BERT THOMAS CEO 40.00 X 66740 0 4272 RICH RUMSEY CEO 40.00 X 17308 0 1209 84048 0 5481 0 0 0 0 0 24987 1043474 1024708 74484 2093169 68574 68574 49305 21666 27639 27639 27639 304357 1043474 374834 -70477 -70477 EDUCATIONAL CONFERENCE 900099 140000 140000 OTHER REVENUE 900099 16900 16900 MISCELLANEOUS REVENUE 900099 6201 6201 2000 2000 165101 2284006 165101 0 25736 937614 937614 89529 60514 20062 8953 393972 263674 77990 52308 7492 4843 1660 989 19900 13538 3724 2638 39534 26509 8004 5021 31200 19500 11700 3736 3736 19129 19129 46800 46800 4603 3086 932 585 41907 31760 6235 3912 45119 30253 9135 5731 36396 2857 33539 7068 1148 5920 8219 5511 1664 1044 6708 4498 1358 852 TELEPHONE AND INTERNET 60679 56801 2383 1495 REGISTRY 27558 27558 SOFTWARE 18132 12158 3671 2303 PROMOTIONAL MATERIALS 18023 12085 3649 2289 40417 13714 24352 2351 1903735 1527621 238843 137271 167114 240428 1275909 1366257 69293 228981 80886 68472 83094 38854 48925 44240 4034718 4415223 5416 4946 5682261 6368547 86987 83224 349624 437614 30000 6200 466611 527038 X 2011788 2480976 3203862 3360533 5215650 5841509 5682261 6368547 380271 245588 0 X 0 1 X 1 0 X 2608202 3518296 1335557 2027706 2093169 11582930 423403 513459 363168 249317 304358 1853705 3031605 4031755 1698725 2277023 2397527 13436635 0 0 0 13436635 43723 56355 66500 67767 68574 302919 43723 56355 66500 67767 68574 302919 30481 53776 104497 115788 165101 469643 3105809 4141886 1869722 2460578 2631202 14209197 0.94560 0.95760 0.02130 0.02070 X 1119 3443 4562 1928328 1932890 246645 61661 0 0 256290 238110 239320 246645 980365 1470548 4902 5956 8597 4562 24017 64073 59528 59830 61661 245092 367638 373 398 923 1119 2813 0 270676 2531 273207 0.63000 0.37000 0 0 30651 19641 11010 52443 19213 33230 44240 X 2558749 245588 29155 274743 2284006 0 2284006 1932890 29155 29155 1903735 0 1903735 PART X, LINE 2: INCOME TAXES NO PROVISION HAS BEEN MADE FOR INCOME TAXES, SINCE THE ORGANIZATION HAS BEEN DETERMINED TO BE EXEMPT FROM INCOME TAX PURSUANT TO INTERNAL REVENUE CODE SECTION 501(C)(3). THERE WAS NO NET UNRELATED BUSINESS TAXABLE INCOME DURING THE YEAR. THE ORGANIZATION ADOPTED THE FINANCIAL ACCOUNTING STANDARDS BOARD FASB ASC 740-10, INCOME TAXES, WHICH REQUIRES AN ASSESSMENT OF UNCERTAINTY IN INCOME TAXES AND CERTAIN FINANCIAL STATEMENT DISCLOSURES RELATING TO UNRECOGNIZED TAX BENEFITS. FOR THE YEAR ENDED DECEMBER 31, 2017, THE ORGANIZATION HAS DETERMINED THAT NO MATERIAL UNCERTAIN TAX POSITIONS EXIST REQUIRING EITHER RECOGNITION OR DISCLOSURE IN THE FINANCIAL STATEMENTS. NO RETURNS ARE CURRENTLY UNDER EXAMINATION. THE ORGANIZATION HAS NOT RECOGNIZED ANY CUMULATIVE ADJUSTMENT RELATING TO THE ADOPTION OF FASB ASC INCOME TAX TOPIC, NOR ARE THERE ANY UNRECOGNIZED TAX BENEFITS TO BE DISCLOSED AS OF DECEMBER 31, 2017. UNCERTAINTY IN INCOME TAXES FOR A NOT-FOR-PROFIT ORGANIZATION WOULD INCLUDE THE STATUS OF ITS EXEMPTION FROM TAXES, STATUS OF FILINGS IN LOCAL JURISDICTIONS, AND UNRELATED BUSINESS INCOME, IF ANY. THE ORGANIZATION'S INFORMATION RETURN FILINGS FOR THE YEARS 2014-2016 REMAIN SUBJECT TO EXAMINATION BY THE INTERNAL REVENUE SERVICE AND STATE AUTHORITES. THE FEDERAL AND STATE RETURNS FOR THE YEAR ENDED DECEMBER 31, 2017, HAVE NOT YET BEEN FILED. X X X 1 POWERED BY PROFESSIONALS INC 1460 BROADWAY 9TH FLOOR NEW YORK NY 10036 CONSULTING, MANAGEMENT, AND FUNDRAISING SERVICES FOR GALA 0 476408 46800 429608 476408 46800 429608 CA CT FL GA IL MA MD MI MN NC NJ NY OR VA WI MS RI TN UT WV AL PA SC KY CO OH WA MO AK AR DC HI KS ME NV NH NM OK GALA 476408 298852 177556 76875 0 9300 73495 STL 6K 170169 130135 40034 500 5196 3232 19292 13 701254 614487 86767 6449 24085 2400 153560 1347831 1043474 304357 83824 29281 14932 246347 374384 -70027 SCHEDULE G, PART I, LINE 2B, COLUMN (V) CURRENT CONTRACT- $6,500 PER MONTH. CURRENT YEAR PORTION RELATED TO EVENT MANAGEMENT: $31,200, PORTION RELATED TO FRP: $46,800. 1 SARC 861087705 501C3 100000 CANCER RESEARCH SITEMAN CANCER CENTER 430653611 501C3 71191 CANCER RESEARCH UNIVERSITY OF PITTSBURGH 250965591 501C3 66055 CANCER RESEARCH FOX CHASE CANCER CENTER 232003072 501C3 13164 CANCER RESEARCH CU FOUNDATION 521749045 501C3 46979 CANCER RESEARCH UNIVERSITY OF PITTSBURGH 113708851 501C3 50000 CANCER RESEARCH UNIVERSITY OF FLORIDA 596002052 501C3 50000 CANCER RESEARCH UNIVERSITY OF MINNESOTA-TWIN CITIES 416007513 501C3 100000 CANCER RESEARCH TUFTS MEDICAL CENTER 043400617 501C3 50000 CANCER RESEARCH DUKE UNIVERSITY 560532129 501C3 50000 CANCER RESEARCH ROSWELL PARK CANCER INSTITUTE 141402155 501C3 50000 CANCER RESEARCH MEMORIAL SLOAN-KETTERING CANCER CENTER 131924236 501C3 50000 CANCER RESEARCH ST JUDE CHILDREN'S RESEARCH HOSPITAL 620646012 501C3 50000 CANCER RESEARCH WASHINGTON UNIVERSITY IN ST LOUIS 430653611 501C3 50000 CANCER RESEARCH CONQUER CANCER FOUNDATION 311667995 501C3 64000 CANCER RESEARCH MEDICAL COLLEGE OF WISCONSIN 390806261 501C3 17757 CANCER RESEARCH LURIE CANCER CENTER 362167817 501C3 34585 CANCER RESEARCH VANDERBILT-INGRAM CANCER CENTER 352528741 501C3 19606 CANCER RESEARCH PART I, LINE 2: APPLICANTS FOR SFA GRANTS MUST SUBMIT AN APPLICATION OUTLINING THEIR PROPOSED RESEARCH PROJECT ALONG WITH A DETAILED BUDGET THAT DEMONSTRATES HOW THE AWARD MONEY IS TO BE USED. APPLICANTS ARE MADE AWARE THAT A REQUIREMENT OF THE ACCEPTANCE OF GRANT MONEY IS THAT A FINAL REPORT WILL BE SUBMITTED TO SFA AT THE END OF THE ONE-YEAR GRANT PERIOD. THE FINAL REPORT AND BUDGET IS DUE TO SFA BY JULY 31ST OF THE YEAR AFTER THE AWARD IS MADE. FINAL REPORTS ARE TO CONTAIN INFORMATION ON HOW THE RESEARCH PROGRESSES AND IT MUST BE SIGNED BY BOTH THE PRIMARY INVESTIGATOR AS WELL AS THEIR DEPARTMENT CHAIR. MARK THORNTON MARK THORNTON, PRESIDENT OF SFA IS ON THE BOARD OF S.A.R.C 100000 S.A.R.C, A 501(C)(3) ORGANIZATION RECEIVED A GRANT FROM SARCOMA FOUNDATION OF AMERICA FOR CANCER RESEARCH. 0 X 5 8250 FMV X 1650 FMV X 2 54527 FMV X 9 4900 FMV X PROMOTIONAL GOODS 3 2882 FMV X TICKETS 6 2275 FMV 0 0 1 PART I, LINE 32B: POWERED BY PROFESSIONAL SOLICITS AND PROCESSES SILENT AUCTION OF ANNUAL GALA. FORM 990, PART VI, SECTION A, LINE 2 MARK THORNTON, PRESIDENT, AND PATRICIA THORNTON, ASSISTANT TREASURER, ARE HUSBAND AND WIFE. FORM 990, PART VI, SECTION B, LINE 11B THE BOOKKEEPER, ASSISTANT TREASURER AND CEO REVIEW THE 990 BASED ON THE FINANCIAL RECORDS, POLICIES AND PROGRAMS OF THE ORGANIZATION. FORM 990, PART VI, SECTION B, LINE 12C AT LEAST ONCE A YEAR, OFFICERS ACTING ON BEHALF OF THE SARCOMA FOUNDATION OF AMERICA, INC., SHALL EXECUTE AND SUBMIT A STATEMENT TO THE PRESIDENT DISCLOSING ALL MATERIAL FACTS CONCERNING ANY ACTUAL OR POTENTIAL CONFLICT OF INTEREST OR CONFIRMING THAT THERE ARE NO SUCH CONFLICTS TO BE DISCLOSED. FORM 990, PART VI, SECTION B, LINE 15A THE BOARD OF DIRECTORS HAS AN APPOINTED COMPENSATION COMMITTEE THAT REVIEWS AND APPROVES THE SALARY OF THE CEO ON AN ANNUAL BASIS USING CURRENT ECONOMIC COMPARATIVE DATA. FORM 990, PART VI, SECTION C, LINE 19 GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY ARE AVAILABLE UPON REQUEST. FINANCIAL STATEMENTS ARE AVAILABLE ON THE WEBSITE AS WELL AS UPON REQUEST.